Moderna intends to expand a COVID-19 vaccine trial among kids under 12 to better monitor for potential rare side effects, a spokesperson confirmed to Fox News

Moderna intends to expand a COVID-19 vaccine trial among kids under 12 to better monitor for potential rare side effects, a spokesperson confirmed to Fox News